Common antigenicity for two glycosidases. - Archive ouverte HAL
Article Dans Une Revue FEBS Letters Année : 2006

Common antigenicity for two glycosidases.

Résumé

Enzyme replacement therapy (ERT) has proven to be an effective therapy for some lysosomal storage disorder (LSD) patients. A potential complication during ERT is the generation of an immune response against the replacement protein. We have investigated the antigenicity of two distantly related glycosidases, α-glucosidase (Pompe disease or glycogen storage disease type II, GSD II), and α-l-iduronidase (Hurler syndrome, mucopolysaccharidosis type I, MPS I). The linear sequence epitope reactivity of affinity purified polyclonal antibodies to recombinant human α-glucosidase and α-l-iduronidase was defined, to both glycosidases. The polyclonal antibodies exhibited some cross-reactive epitopes on the two proteins. Moreover, a monoclonal antibody to the active site of α-glucosidase showed cross-reactivity with a catalytic structural element of α-l-iduronidase. In a previous study, in MPS I patients who developed an immune response to ERT, this same site on α-l-iduronidase was highly antigenic and the last to tolerise following repeated enzyme infusions. We conclude that glycosidases can exhibit cross-reactive epitopes, and infer that this may relate to common structural elements associated with their active sites.

Dates et versions

hal-00022577 , version 1 (11-04-2006)

Identifiants

Citer

Revecca Kakavanos, Pierre Lehn, Isabelle Callebaut, Peter J. Meiklea, Emma J. Parkinson-Lawrence, et al.. Common antigenicity for two glycosidases.. FEBS Letters, 2006, 580, pp.87-92. ⟨10.1016/j.febslet.2005.11.053⟩. ⟨hal-00022577⟩
115 Consultations
0 Téléchargements

Altmetric

Partager

More